Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Orthopediatrics (KIDS) Change in Account Payables (2016 - 2025)

Historic Change in Account Payables for Orthopediatrics (KIDS) over the last 10 years, with Q3 2025 value amounting to -$5.7 million.

  • Orthopediatrics' Change in Account Payables rose 400.47% to -$5.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$4.5 million, marking a year-over-year increase of 6199.34%. This contributed to the annual value of -$4.3 million for FY2024, which is 38705.57% down from last year.
  • According to the latest figures from Q3 2025, Orthopediatrics' Change in Account Payables is -$5.7 million, which was up 400.47% from -$1.5 million recorded in Q2 2025.
  • Orthopediatrics' 5-year Change in Account Payables high stood at $6.6 million for Q1 2024, and its period low was -$10.0 million during Q4 2023.
  • Moreover, its 5-year median value for Change in Account Payables was $40000.0 (2022), whereas its average is -$290842.1.
  • Within the past 5 years, the most significant YoY rise in Orthopediatrics' Change in Account Payables was 1035750.0% (2023), while the steepest drop was 565611.11% (2023).
  • Quarter analysis of 5 years shows Orthopediatrics' Change in Account Payables stood at $389000.0 in 2021, then crashed by 53.73% to $180000.0 in 2022, then tumbled by 5656.11% to -$10.0 million in 2023, then skyrocketed by 74.88% to -$2.5 million in 2024, then crashed by 126.15% to -$5.7 million in 2025.
  • Its Change in Account Payables was -$5.7 million in Q3 2025, compared to -$1.5 million in Q2 2025 and $5.2 million in Q1 2025.